🇺🇸 FDA
Pipeline program

CS-3150

CS3150-A-J306

Phase 3 small_molecule completed

Quick answer

CS-3150 for Hypertension is a Phase 3 program (small_molecule) at Daiichi Sankyo with 1 ClinicalTrials.gov record(s).

Program details

Company
Daiichi Sankyo
Indication
Hypertension
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials